Cargando…

Rosiglitazone and Risk of Cancer: A meta-analysis of randomized clinical trials

OBJECTIVE—Despite experimental data suggesting a protective effect of peroxisome proliferator–activated receptor-γ agonists with respect to malignancies, results of available epidemiological studies on the incidence of cancer in rosiglitazone-treated patients are not univocal. The aim of this meta-a...

Descripción completa

Detalles Bibliográficos
Autores principales: Monami, Matteo, Lamanna, Caterina, Marchionni, Niccolò, Mannucci, Edoardo
Formato: Texto
Lenguaje:English
Publicado: American Diabetes Association 2008
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2453648/
https://www.ncbi.nlm.nih.gov/pubmed/18375416
http://dx.doi.org/10.2337/dc07-2308